[go: up one dir, main page]

DE60327554D1 - Wasserfreies kristallines azidocytosin-hemisulfat-derivat - Google Patents

Wasserfreies kristallines azidocytosin-hemisulfat-derivat

Info

Publication number
DE60327554D1
DE60327554D1 DE60327554T DE60327554T DE60327554D1 DE 60327554 D1 DE60327554 D1 DE 60327554D1 DE 60327554 T DE60327554 T DE 60327554T DE 60327554 T DE60327554 T DE 60327554T DE 60327554 D1 DE60327554 D1 DE 60327554D1
Authority
DE
Germany
Prior art keywords
hemisulate
azidocytosine
derivative
water
free crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60327554T
Other languages
English (en)
Inventor
Terrence Joseph Connolly
Joseph Armstrong Martin
Anthony Prince
Keshab Sarma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60327554D1 publication Critical patent/DE60327554D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE60327554T 2002-12-09 2003-12-08 Wasserfreies kristallines azidocytosin-hemisulfat-derivat Expired - Lifetime DE60327554D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43188502P 2002-12-09 2002-12-09
PCT/EP2003/013899 WO2004052906A1 (en) 2002-12-09 2003-12-08 Anhydrous crystalline azido cytosine hemisulfate derivative

Publications (1)

Publication Number Publication Date
DE60327554D1 true DE60327554D1 (de) 2009-06-18

Family

ID=32507815

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60327554T Expired - Lifetime DE60327554D1 (de) 2002-12-09 2003-12-08 Wasserfreies kristallines azidocytosin-hemisulfat-derivat

Country Status (32)

Country Link
US (1) US6864244B2 (de)
EP (1) EP1572711B1 (de)
JP (1) JP4563818B2 (de)
KR (1) KR100675544B1 (de)
CN (1) CN1314697C (de)
AR (1) AR042312A1 (de)
AT (1) ATE430755T1 (de)
AU (1) AU2003292212B2 (de)
BR (1) BR0317146A (de)
CA (1) CA2506532C (de)
CY (1) CY1109296T1 (de)
DE (1) DE60327554D1 (de)
DK (1) DK1572711T3 (de)
ES (1) ES2324654T3 (de)
GT (1) GT200300276A (de)
HR (1) HRP20050503A2 (de)
IL (1) IL168685A (de)
JO (1) JO2542B1 (de)
MX (1) MXPA05006044A (de)
MY (1) MY130927A (de)
NO (1) NO330454B1 (de)
NZ (1) NZ540297A (de)
PA (1) PA8590701A1 (de)
PE (1) PE20040767A1 (de)
PL (1) PL213734B1 (de)
PT (1) PT1572711E (de)
RU (1) RU2334756C2 (de)
SI (1) SI1572711T1 (de)
TW (1) TWI294882B (de)
UY (1) UY28109A1 (de)
WO (1) WO2004052906A1 (de)
ZA (1) ZA200504472B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4577751B2 (ja) * 1999-09-02 2010-11-10 塩野義製薬株式会社 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤
CA2284459C (en) 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
US20050182252A1 (en) * 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
DE602005015466D1 (de) * 2004-08-23 2009-08-27 Hoffmann La Roche Antivirale 4'-azidonucleoside
SI2084175T1 (sl) * 2006-10-10 2011-05-31 Medivir Ab Hcv nukleozidni inhibitor
JP2010515680A (ja) 2007-01-05 2010-05-13 メルク・シャープ・エンド・ドーム・コーポレイション Ｒｎａ依存性ｒｎａウイルス感染症の治療用としてのヌクレオシドアリールホスホロアミデート
GB0709791D0 (en) * 2007-05-22 2007-06-27 Angeletti P Ist Richerche Bio Antiviral agents
GB0900914D0 (en) 2009-01-20 2009-03-04 Angeletti P Ist Richerche Bio Antiviral agents
CA2812962C (en) 2010-09-22 2020-03-31 Alios Biopharma, Inc. Azido nucleosides and nucleotide analogs
CA2937548C (en) 2014-02-13 2022-10-25 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN103965116B (zh) * 2014-05-06 2016-06-15 中国科学院苏州纳米技术与纳米仿生研究所 半5-氟胞嘧啶盐、其制备方法及应用
WO2016003812A1 (en) 2014-07-02 2016-01-07 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
GEP20237502B (en) 2015-03-06 2023-04-25 Atea Pharmaceuticals Inc B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
EA202190602A3 (ru) 2016-09-07 2021-11-30 Атеа Фармасьютикалс, Инк. 2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний
GEP20237457B (en) 2017-02-01 2023-01-10 Atea Pharmaceuticals Inc Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
JP2021521118A (ja) 2018-04-10 2021-08-26 アテア ファーマシューティカルズ， インコーポレイテッド 肝硬変を伴うｈｃｖ感染患者の治療
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
KR20240022574A (ko) 2021-06-17 2024-02-20 아테아 파마슈티컬즈, 인크. 유리한 항-hcv 조합 요법
CN115536710B (zh) * 2022-10-18 2024-04-16 南京工业大学 一种高品质胞苷硫酸盐晶体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449664A (en) * 1988-11-21 1995-09-12 Syntex (U.S.A.) Inc. Antiviral agents
PH27609A (en) * 1988-11-21 1993-08-31 Syntex Inc Antiviral agents
AU7623991A (en) * 1990-05-17 1991-11-21 Syntex (U.S.A.) Inc. Antiviral agents
PT1027359E (pt) * 1996-10-16 2003-09-30 Ribapharm Inc L-nucleosideos monociclicos analogos e suas utilizacoes
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
SI1355916T1 (sl) * 2001-01-22 2007-04-30 Merck & Co Inc Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives

Also Published As

Publication number Publication date
AU2003292212B2 (en) 2009-10-01
NO330454B1 (no) 2011-04-18
HRP20050503A2 (en) 2006-12-31
HK1085483A1 (en) 2006-08-25
JO2542B1 (en) 2010-09-05
AU2003292212A1 (en) 2004-06-30
DK1572711T3 (da) 2009-07-13
TWI294882B (en) 2008-03-21
CY1109296T1 (el) 2014-07-02
WO2004052906A1 (en) 2004-06-24
CN1723215A (zh) 2006-01-18
PA8590701A1 (es) 2004-11-26
NO20052732D0 (no) 2005-06-07
CA2506532C (en) 2011-09-20
UY28109A1 (es) 2004-06-30
PE20040767A1 (es) 2004-11-06
KR20050084217A (ko) 2005-08-26
MY130927A (en) 2007-07-31
NZ540297A (en) 2007-05-31
CN1314697C (zh) 2007-05-09
US6864244B2 (en) 2005-03-08
KR100675544B1 (ko) 2007-01-30
MXPA05006044A (es) 2005-08-18
JP4563818B2 (ja) 2010-10-13
GT200300276A (es) 2004-09-02
RU2005121927A (ru) 2006-01-27
RU2334756C2 (ru) 2008-09-27
ATE430755T1 (de) 2009-05-15
ES2324654T3 (es) 2009-08-12
ZA200504472B (en) 2006-02-22
NO20052732L (no) 2005-09-06
AR042312A1 (es) 2005-06-15
PL377472A1 (pl) 2006-02-06
PL213734B1 (pl) 2013-04-30
US20040162265A1 (en) 2004-08-19
EP1572711B1 (de) 2009-05-06
SI1572711T1 (sl) 2009-08-31
TW200502243A (en) 2005-01-16
CA2506532A1 (en) 2004-06-24
PT1572711E (pt) 2009-06-25
EP1572711A1 (de) 2005-09-14
BR0317146A (pt) 2005-10-25
IL168685A (en) 2010-11-30
JP2006510649A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
ATE450506T1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
FR14C0045I2 (fr) Nouveau derive de 2-pyridylethylbenzamide
DK1594840T3 (da) Piperidin-benzensulfonamid-derivater
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
ATE352550T1 (de) Chinazolinderivate
DK1682493T3 (da) Amidoacetonitrilderivater
DE60327554D1 (de) Wasserfreies kristallines azidocytosin-hemisulfat-derivat
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
ATE308543T1 (de) Piperidinderivate
ATE454381T1 (de) Benzofuranderivat
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
DK1682129T3 (da) N-thiazol-2-ylbenzamidderivater
ATE423771T1 (de) Tetrahydrochinolinderivate
ATE457299T1 (de) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ
DK1706373T3 (da) Amidoacetonitrilderivater
IS8045A (is) Púrín-6-ón-afleiður
DE50306277D1 (de) 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
IS7906A (is) Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls

Legal Events

Date Code Title Description
8364 No opposition during term of opposition